comparemela.com

Latest Breaking News On - Linda wu - Page 4 : comparemela.com

Asieris Obtained IND Approval from NMPA for APL-1401, a Drug for the Treatment of Moderately-to-Severely Active Ulcerative Colitis

Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer

/PRNewswire/ Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.